Skip to content

Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy

Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06262893
Enrollment
60
Registered
2024-02-16
Start date
2024-02-25
Completion date
2026-01-01
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dexamethasone, Shoulder Arthroscopy Blocks

Brief summary

In this study the investigators aim to compare the effect of the suprascapular- supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on analgesic effect during arthroscopic shoulder surgery, as postoperative pain scores ,postoperative consumption of analgesic rescue medications and diaphragmatic excursion assessment.

Interventions

PROCEDUREShoulder arthroscopy blocks

Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA status 1,2. * Age 18 years or older * Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively.

Exclusion criteria

* • Patient refusal * Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease. * Use of drugs that act on the autonomic nervous system (including β- blockers). * Coagulation disorders.. * Anatomical disorders and/or neuropathic disease. * BMI above 40. * History of substance abuse. * Chronic use of psychotropic and/or opioid. * History of psychiatric diseases needing treatment. * Allergy to any drug in the study protocol. * Failure of nerve block performed in the preoperative block room when tested prior to entering the operating room (i.e. lack of loss of sensation to ice at the shoulder incision level).

Design outcomes

Primary

MeasureTime frameDescription
Postoperative analgesia by visual analog scale (VAS).48 hoursThe primary outcome of this study will be to evaluate and compare between suprascapular-supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on postoperative analgesia by vas score during 48h postoperatively ( 2h , 6h , 12h, 24h and 48h). The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

Secondary

MeasureTime frameDescription
Diaphragmatic excursion1hour postoperativelyAssessment of diaphragmatic excursion by ultrasound preoperatively and 1hour postoperatively

Countries

Egypt

Contacts

Primary ContactMohamed Ahmed
mohamedelkhatib90@gmail.com01151994269
Backup ContactMohamed Talaat
+20 106 201 2031

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026